Literature DB >> 29671605

Effects of budesonide and surfactant in preterm fetal sheep.

T Brett Kothe1, Emily Royse1, Matthew W Kemp2, Augusto Schmidt3, Fabrizio Salomone4, Masatoshi Saito5, Haruo Usuda2,5, Shimpei Watanabe5, Gabrielle C Musk6, Alan H Jobe3,2, Noah H Hillman1.   

Abstract

Mechanical ventilation causes lung injury and systemic inflammatory responses in preterm sheep and is associated with bronchopulmonary dysplasia (BPD) in preterm infants. Budesonide added to surfactant decreased BPD by 20% in infants. We wanted to determine the effects of budesonide and surfactant on injury from high tidal volume (VT) ventilation in preterm lambs. Ewes at 125 ± 1 days gestational age had fetal surgery to expose fetal head and chest with placental circulation intact. Lambs were randomized to 1) mechanical ventilation with escalating VT to target 15 ml/kg by 15 min or 2) continuous positive airway pressure (CPAP) of 5 cmH2O. After the 15-min intervention, lambs were given surfactant 100 mg/kg with saline, budesonide 0.25 mg/kg, or budesonide 1 mg/kg. The fetuses were returned to the uterus for 24 h and then delivered and ventilated for 30 min to assess lung function. Budesonide levels were low in lung and plasma. CPAP groups had improved oxygenation, ventilation, and decreased injury markers compared with fetal VT lambs. Budesonide improved ventilation in CPAP lambs. Budesonide decreased lung weights and lung liquid and increased lung compliance and surfactant protein mRNA. Budesonide decreased proinflammatory and acute-phase responses in lung. Airway thickness increased in animals not receiving budesonide. Systemically, budesonide decreased monocyte chemoattractant protein-1 mRNA and preserved glycogen in liver. Results with 0.25 and 1 mg/kg budesonide were similar. We concluded that budesonide with surfactant matured the preterm lung and decreased the liver responses but did not improve lung function after high VT injury in fetal sheep.

Entities:  

Keywords:  airway; bronchopulmonary dysplasia; inflammation; mechanical ventilation; preterm

Mesh:

Substances:

Year:  2018        PMID: 29671605      PMCID: PMC6139660          DOI: 10.1152/ajplung.00528.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  40 in total

1.  Effect of decreased fetal perfusion on placental clearance of volatile anesthetics in a dual perfused human placental cotyledon model.

Authors:  Ryusuke Ueki; Tsuneo Tatara; Nobutaka Kariya; Noriko Shimode; Munetaka Hirose; Chikara Tashiro
Journal:  J Anesth       Date:  2014-01-03       Impact factor: 2.078

Review 2.  Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis.

Authors:  Hendrik S Fischer; Christoph Bührer
Journal:  Pediatrics       Date:  2013-10-21       Impact factor: 7.124

3.  Injury and repair in the very immature lung following brief mechanical ventilation.

Authors:  Nadine Brew; Stuart B Hooper; Beth J Allison; Megan J Wallace; Richard Harding
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-02       Impact factor: 5.464

4.  Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

Authors:  Matthew M Laughon; John C Langer; Carl L Bose; P Brian Smith; Namasivayam Ambalavanan; Kathleen A Kennedy; Barbara J Stoll; Susie Buchter; Abbot R Laptook; Richard A Ehrenkranz; C Michael Cotten; Deanne E Wilson-Costello; Seetha Shankaran; Krisa P Van Meurs; Alexis S Davis; Marie G Gantz; Neil N Finer; Bradley A Yoder; Roger G Faix; Waldemar A Carlo; Kurt R Schibler; Nancy S Newman; Wade Rich; Abhik Das; Rosemary D Higgins; Michele C Walsh
Journal:  Am J Respir Crit Care Med       Date:  2011-03-04       Impact factor: 21.405

5.  Moderate tidal volumes and oxygen exposure during initiation of ventilation in preterm fetal sheep.

Authors:  Noah H Hillman; Timothy J Moss; Ilias Nitsos; Alan H Jobe
Journal:  Pediatr Res       Date:  2012-10-04       Impact factor: 3.756

6.  Evidence of the in vivo esterification of budesonide in human airways.

Authors:  Karen I Maassen van den Brink; Martin Boorsma; A Jeske Staal-van den Brekel; Staffam Edsbäcker; Emiel F Wouters; Lars Thorsson
Journal:  Br J Clin Pharmacol       Date:  2008-04-01       Impact factor: 4.335

7.  Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study.

Authors:  Tsu F Yeh; Hong C Lin; Chien H Chang; Tien S Wu; Bai H Su; Tsai C Li; Suma Pyati; Chang H Tsai
Journal:  Pediatrics       Date:  2008-04-21       Impact factor: 7.124

8.  Airway injury from initiating ventilation in preterm sheep.

Authors:  Noah H Hillman; Suhas G Kallapur; J Jane Pillow; Timothy J M Moss; Graeme R Polglase; Ilias Nitsos; Alan H Jobe
Journal:  Pediatr Res       Date:  2010-01       Impact factor: 3.756

Review 9.  Review of the unique properties of budesonide.

Authors:  Edward J O'Connell
Journal:  Clin Ther       Date:  2003       Impact factor: 3.393

10.  Sustained inflation at birth did not alter lung injury from mechanical ventilation in surfactant-treated fetal lambs.

Authors:  Noah H Hillman; Matthew W Kemp; Yuichiro Miura; Suhas G Kallapur; Alan H Jobe
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

View more
  7 in total

1.  Surfactant plus budesonide decreases lung and systemic responses to injurious ventilation in preterm sheep.

Authors:  Noah H Hillman; T Brett Kothe; Augusto F Schmidt; Matthew W Kemp; Emily Royse; Erin Fee; Fabrizio Salomone; Michael W Clarke; Gabrielle C Musk; Alan H Jobe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

2.  Surfactant plus budesonide decreases lung and systemic inflammation in mechanically ventilated preterm sheep.

Authors:  T Brett Kothe; Matthew W Kemp; Augusto Schmidt; Emily Royse; Fabrizio Salomone; Michael W Clarke; Gabrielle C Musk; Alan H Jobe; Noah H Hillman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-06       Impact factor: 5.464

Review 3.  Surfactant replacement therapy: from biological basis to current clinical practice.

Authors:  Roland Hentschel; Kajsa Bohlin; Anton van Kaam; Hans Fuchs; Olivier Danhaive
Journal:  Pediatr Res       Date:  2020-01-11       Impact factor: 3.756

Review 4.  Oxidative Stress and Respiratory Diseases in Preterm Newborns.

Authors:  Laura Cannavò; Serafina Perrone; Valeria Viola; Lucia Marseglia; Gabriella Di Rosa; Eloisa Gitto
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

Review 5.  The benefits, limitations and opportunities of preclinical models for neonatal drug development.

Authors:  Sarah Campion; Amy Inselman; Belinda Hayes; Costanza Casiraghi; David Joseph; Fabrizio Facchinetti; Fabrizio Salomone; Georg Schmitt; Julia Hui; Karen Davis-Bruno; Karen Van Malderen; LaRonda Morford; Luc De Schaepdrijver; Lutz Wiesner; Stephanie Kourula; Suna Seo; Susan Laffan; Vijay Urmaliya; Connie Chen
Journal:  Dis Model Mech       Date:  2022-04-25       Impact factor: 5.732

6.  Surfactant-Assisted Distal Pulmonary Distribution of Budesonide Revealed by Mass Spectrometry Imaging.

Authors:  Riccardo Zecchi; Pietro Franceschi; Laura Tigli; Barbara Pioselli; Valentina Mileo; Xabier Murgia; Fabrizio Salomone; Giuseppe Pieraccini; Haruo Usada; Augusto F Schmidt; Noah H Hillman; Matthew W Kemp; Alan H Jobe
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

Review 7.  Strategies to protect surfactant and enhance its activity.

Authors:  Daniele De Luca; Chiara Autilio
Journal:  Biomed J       Date:  2021-08-05       Impact factor: 4.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.